Bergson S, Sarig O, Giladi M, Mohamad J, Mogezel-Salem M, Smorodinsky-Atias K
J Exp Med. 2025; 222(5).
PMID: 39976600
PMC: 11841684.
DOI: 10.1084/jem.20240827.
Outla Z, Prechova M, Korelova K, Gemperle J, Gregor M
Open Biol. 2025; 15(1):240208.
PMID: 39875099
PMC: 11774597.
DOI: 10.1098/rsob.240208.
Duque J, Bonfanti A, Fouchard J, Baldauf L, Azenha S, Ferber E
Nat Mater. 2024; 23(11):1563-1574.
PMID: 39468334
PMC: 11525174.
DOI: 10.1038/s41563-024-02027-3.
Bchetnia M, Powell J, McCuaig C, Boucher-Lafleur A, Morin C, Dupere A
Int J Mol Sci. 2024; 25(17).
PMID: 39273442
PMC: 11394917.
DOI: 10.3390/ijms25179495.
Dermitzakis I, Chatzi D, Kyriakoudi S, Evangelidis N, Vakirlis E, Meditskou S
Curr Issues Mol Biol. 2024; 46(8):8239-8267.
PMID: 39194704
PMC: 11353016.
DOI: 10.3390/cimb46080487.
Small fiber neuropathy in epidermolysis bullosa simplex.
Babakoohi S, Sipe A, Zamanifekri M, Hunter W
JAAD Case Rep. 2024; 48:23-25.
PMID: 38741659
PMC: 11090054.
DOI: 10.1016/j.jdcr.2024.03.013.
Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.
Gila F, Alamdari-Palangi V, Rafiee M, Jokar A, Ehtiaty S, Dianatinasab A
J Appl Genet. 2024; 65(4):705-726.
PMID: 38459407
DOI: 10.1007/s13353-024-00839-2.
Allele-specific CRISPR-Cas9 editing of dominant epidermolysis bullosa simplex in human epidermal stem cells.
Cattaneo C, Enzo E, De Rosa L, Sercia L, Consiglio F, Forcato M
Mol Ther. 2023; 32(2):372-383.
PMID: 38053334
PMC: 10861943.
DOI: 10.1016/j.ymthe.2023.11.027.
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum.
Sproule T, Wilpan R, Wilson J, Low B, Kabata Y, Ushiki T
PLoS One. 2023; 18(10):e0293218.
PMID: 37883475
PMC: 10602294.
DOI: 10.1371/journal.pone.0293218.
Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation.
Sun J, Li P, Gui H, Rittie L, Lombard D, Rietscher K
JCI Insight. 2023; 8(14).
PMID: 37485877
PMC: 10443796.
DOI: 10.1172/jci.insight.166314.
Intermediate filament network perturbation in the intestine causes systemic dysfunctions.
Geisler F, Remmelzwaal S, Jankowski V, Schmidt R, Boxem M, Leube R
Elife. 2023; 12.
PMID: 37283438
PMC: 10281669.
DOI: 10.7554/eLife.82333.
Stem Cell Therapies for Epidermolysis Bullosa Treatment.
Niti A, Koliakos G, Michopoulou A
Bioengineering (Basel). 2023; 10(4).
PMID: 37106609
PMC: 10135837.
DOI: 10.3390/bioengineering10040422.
Overview of familial syndromes with increased skin malignancies.
Juan H, Zhou A, Hoegler K, Khachemoune A
Arch Dermatol Res. 2022; 315(4):707-727.
PMID: 36342513
DOI: 10.1007/s00403-022-02447-8.
Towards a Better Understanding of Genotype-Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction.
Vermeer M, Andrei D, Marsili L, van Tintelen J, Sillje H, van den Berg M
Int J Mol Sci. 2022; 23(18).
PMID: 36142674
PMC: 9503274.
DOI: 10.3390/ijms231810765.
Eye Involvement and Management in Inherited Epidermolysis Bullosa.
Bachir Y, Daruich A, Marie C, Robert M, Bremond-Gignac D
Drugs. 2022; 82(12):1277-1285.
PMID: 36074321
DOI: 10.1007/s40265-022-01770-8.
Epidermolysis Bullosa-A Different Genetic Approach in Correlation with Genetic Heterogeneity.
Panzaru M, Caba L, Florea L, Braha E, Gorduza E
Diagnostics (Basel). 2022; 12(6).
PMID: 35741135
PMC: 9222206.
DOI: 10.3390/diagnostics12061325.
Keratin Biomaterials in Skin Wound Healing, an Old Player in Modern Medicine: A Mini Review.
Konop M, Rybka M, Drapala A
Pharmaceutics. 2021; 13(12).
PMID: 34959311
PMC: 8705570.
DOI: 10.3390/pharmaceutics13122029.
A Familial Form of Epidermolysis Bullosa Simplex Associated with a Pathogenic Variant in .
Paduano F, Colao E, Grillone T, Vismara M, Amato R, Nistico S
Genes (Basel). 2021; 12(10).
PMID: 34680898
PMC: 8535670.
DOI: 10.3390/genes12101503.
Genetic trend of the junctional epidermolysis bullosa in the German shorthaired pointer in Italy.
Frattini S, Polli M, Cortellari M, Negro A, Bionda A, Riva J
Vet Rec Open. 2021; 8(1):e15.
PMID: 34457315
PMC: 8374380.
DOI: 10.1002/vro2.15.
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues.
Vermeer M, Bolling M, Bliley J, Arevalo Gomez K, Pavez-Giani M, Kramer D
J Clin Invest. 2021; .
PMID: 34292882
PMC: 8409593.
DOI: 10.1172/JCI140615.